These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33038615)

  • 1. Generation of homozygous CRISPRa human induced pluripotent stem cell (hiPSC) lines for sustained endogenous gene activation.
    Schoger E; Argyriou L; Zimmermann WH; Cyganek L; Zelarayán LC
    Stem Cell Res; 2020 Oct; 48():101944. PubMed ID: 33038615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a second generation homozygous CRISPRa human induced pluripotent stem cell (hiPSC) line for enhanced levels of endogenous gene activation.
    Schoger E; Zimmermann WH; Cyganek L; Zelarayán LC
    Stem Cell Res; 2021 Oct; 56():102518. PubMed ID: 34481190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of two homozygous CRISPR interference (CRISPRi) knock-in human induced pluripotent stem cell (hiPSC) lines for titratable endogenous gene repression.
    Schoger E; Zimmermann WH; Cyganek L; Zelarayán LC
    Stem Cell Res; 2021 Aug; 55():102473. PubMed ID: 34343828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
    Zhang Y; Sastre D; Wang F
    Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Massively parallel characterization of CRISPR activator efficacy in human induced pluripotent stem cells and neurons.
    Wu Q; Wu J; Karim K; Chen X; Wang T; Iwama S; Carobbio S; Keen P; Vidal-Puig A; Kotter MR; Bassett A
    Mol Cell; 2023 Apr; 83(7):1125-1139.e8. PubMed ID: 36917981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium.
    Karbassi E; Padgett R; Bertero A; Reinecke H; Klaiman JM; Yang X; Hauschka SD; Murry CE
    Cell Mol Life Sci; 2024 Feb; 81(1):95. PubMed ID: 38372898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiplexed gRNA piggyBac transposon system facilitates efficient induction of CRISPRi and CRISPRa in human pluripotent stem cells.
    Hazelbaker DZ; Beccard A; Angelini G; Mazzucato P; Messana A; Lam D; Eggan K; Barrett LE
    Sci Rep; 2020 Jan; 10(1):635. PubMed ID: 31959800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient introduction of an isogenic homozygous mutation to induced pluripotent stem cells from a hereditary hearing loss family using CRISPR/Cas9 and single-stranded donor oligonucleotides.
    Dong Y; Peng T; Wu W; Tan D; Liu X; Xie D
    J Int Med Res; 2019 Apr; 47(4):1717-1730. PubMed ID: 30819013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Modulation of Chicken Genes In Vitro Using CRISPRa and CRISPRi Toolkit.
    Chapman B; Han JH; Lee HJ; Ruud I; Kim TH
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining a tetracycline (Tet)-inducible gRNA system and CRISPRa for titratable and timely controlled enhancement of endogenous SHISA3 activation in human induced pluripotent stem cells (hiPSC).
    Priesmeier L; Schoger E; Cyganek L; Cecilia Zelarayán L
    Stem Cell Res; 2023 Sep; 71():103163. PubMed ID: 37433260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a gene corrected human isogenic IBMS-iPSC-014-C from polycystic-kidney-disease induced pluripotent stem cell line using CRISPR/Cas9.
    Liu CL; Huang CY; Chen HC; Lu HE; Hsieh PCH; Lee JJ
    Stem Cell Res; 2020 May; 45():101784. PubMed ID: 32361310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a human Neurochondrin deficient iPSC line KICRi002-A-3 using CRISPR/Cas9.
    Fatima A; Schuster J; Akram T; Sobol M; Hoeber J; Dahl N
    Stem Cell Res; 2020 Apr; 44():101758. PubMed ID: 32203915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a homozygous ARHGAP11B knockout hiPSC line by CRISPR/Cas9 system.
    Liu Y; Jin Y; Chen T; Wu Y; Peng X; Li W; Wei S; Chen M; Zou Q; Guo S; Xu J; Tang C; Zhou X
    Stem Cell Res; 2022 May; 61():102764. PubMed ID: 35358830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human induced pluripotent stem cell line with genetically encoded fluorescent voltage indicator generated via CRISPR for action potential assessment post-cardiogenesis.
    Sun YH; Kao HKJ; Chang CW; Merleev A; Overton JL; Pretto D; Yechikov S; Maverakis E; Chiamvimonvat N; Chan JW; Lieu DK
    Stem Cells; 2020 Jan; 38(1):90-101. PubMed ID: 31566285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9-edited triple-fusion reporter gene imaging of dynamics and function of transplanted human urinary-induced pluripotent stem cell-derived cardiomyocytes.
    Gao Y; Wu S; Pan J; Zhang K; Li X; Xu Y; Jin C; He X; Shi J; Ma L; Wu F; Yao Y; Wang P; He Q; Lan F; Zhang H; Tian M
    Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):708-720. PubMed ID: 33216174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-Mediated Fluorescent Tagging of Endogenous Proteins in Human Pluripotent Stem Cells.
    Sharma A; Toepfer CN; Ward T; Wasson L; Agarwal R; Conner DA; Hu JH; Seidman CE
    Curr Protoc Hum Genet; 2018 Jan; 96():21.11.1-21.11.20. PubMed ID: 29364519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR technologies for stem cell engineering and regenerative medicine.
    Hsu MN; Chang YH; Truong VA; Lai PL; Nguyen TKN; Hu YC
    Biotechnol Adv; 2019 Dec; 37(8):107447. PubMed ID: 31513841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Eukaryote-Like CRISPR Activation Tool in Bacteria: Features and Capabilities.
    Liu Y; Wang B
    Bioessays; 2020 Jun; 42(6):e1900252. PubMed ID: 32310310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Han HJ; Seo HH; Han HW; Kim JH
    Stem Cell Res; 2019 Oct; 40():101520. PubMed ID: 31445394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.